Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,001–1,008 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
BioNTech SE Pumitamig - (China trial/ROSETTA HCC-206) 1L HCC Phase 2 Ongoing Intravenous Oncology
BioNTech SE Pumitamig - (ROSETTA Lung-01) 1L ES-SCLC Phase 2 Ongoing Intravenous Oncology
BioNTech SE BNT162b5 COVID-19 vaccine Phase 2 Intramuscular COVID-19
BioNTech SE Gotistobart (BNT316/ONC-392) with lutetium Lu 177 vipivotide tetraxetan (Lu 177) Metastatic castration-resistant prostate cancer (mCRPC) Phase 2 Ongoing Intravenous Oncology
BioNTech SE Pumitamig 1L HER2- PD-L1+ gastric cancer Phase 3 Trial Planned Intravenous Oncology
BioNTech SE BNT327/PM8002 with chemotherapy Triple negative breast cancer Phase 3 IND Clearance Intravenous Oncology
BioNTech SE Autogene cevumeran (BNT122/RO7198457) - (IMCODE004) High-risk muscle-invasive urothelial carcinoma (MIUC) Phase 3 Enrollment Initiation Intravenous Oncology
BioNTech SE BNT323/DB-1303 Advanced endometrial cancer Phase 3 Ongoing Intravenous Oncology